JNBS
Üsküdar Üniversitesi

ARTICLES

Letter to Editor

A novel treatment option for autism spectrum disorder: vasopressin receptor antagonists

Turkish Title : A novel treatment option for autism spectrum disorder: vasopressin receptor antagonists

Çöpür Mazlum,Çöpür Sidar
JNBS, 2020, 7(2), p:98-100

Autism spectrum disorder is a developmental disability affecting 1 in every 59 newborns and causes significant morbidity while exact pathophysiology is unclear. Recent hypothesis includes vasopressin in patients with ASD while vasopressin receptor antagonists including balovaptan appears to be promising option for treatment especially in ASD patients with high functionality. In this study, our aim is to describe recent developments in vasopressin receptor antagonists involving ASD treatment which have potential for future clinical implementation.

Autism spectrum disorder is a developmental disability affecting 1 in every 59 newborns and causes significant morbidity while exact pathophysiology is unclear. Recent hypothesis includes vasopressin in patients with ASD while vasopressin receptor antagonists including balovaptan appears to be promising option for treatment especially in ASD patients with high functionality. In this study, our aim is to describe recent developments in vasopressin receptor antagonists involving ASD treatment which have potential for future clinical implementation.


ISSN (Print) 2149-1909
ISSN (Online) 2148-4325

2020 Ağustos ayından itibaren yalnızca İngilizce yayın kabul edilmektedir.